Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): £62.4 Million

According to Repligen 's latest financial reports the company's current earnings are £0.73 Billion. , an increase over its 2024 earnings that were of -£4.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year	Earnings	Change
2025	£63.07 M	-1430.84%
2024	-£4.74 Million	-113.01%
2023	£36.42 M	-78.01%
2022	£0.16 B	33.37%
2021	£0.12 B	131.52%
2020	£53.64 M	101.31%
2019	£26.64 M	25.93%
2018	£21.16 M	105.61%
2017	£10.29 M	-11.46%
2016	£11.62 M	14.91%
2015	£10.11 M	20.26%
2014	£8.41 M	-51.49%
2013	£17.34 M	90.98%
2012	£9.07 M
2010	£0.13 M	-103.81%
2009	-£3.45 Million	-223.84%
2008	£2.78 M
2006	-£1.88 Million	229.64%
2005	-£0.57 Million	-89.16%
2004	-£5.24 Million	-16.86%
2003	-£6.3 Million	88.72%
2002	-£3.34 Million	-27.88%
2001	-£4.63 Million	-1.74%
2000	-£4.71 Million	85.93%
1999	-£2.54 Million	159.16%
1998	-£0.98 Million	85.71%
1997	-£0.53 Million	-70.83%
1996	-£1.81 Million	-72.41%
1995	-£6.55 Million	-60.63%
1994	-£16.62 Million	45.39%
1993	-£11.43 Million	39.45%
1992	-£8.2 Million	-32.3%
1991	-£12.11 Million	6.62%
1990	-£11.36 Million	1577.78%
1989	-£0.68 Million	-57.14%
1988	-£1.58 Million	-362.5%
1987	£0.6 M	-130.77%
1986	-£1.96 Million	136.36%
1985	-£0.83 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Pfizer PFE	£7.66 B	12,048.37%	🇺🇸 USA
Thermo Fisher Scientific TMO	£5.49 B	8,610.78%	🇺🇸 USA
General Electric GE	£8.15 B	12,824.33%	🇺🇸 USA
Bristol-Myers Squibb BMY	£7.01 B	11,018.53%	🇺🇸 USA
Sangamo Therapeutics SGMO	-£81.98 Million	-229.95%	🇺🇸 USA
Novavax NVAX	£0.28 B	346.97%	🇺🇸 USA
Neurocrine Biosciences NBIX	£0.47 B	658.68%	🇺🇸 USA
Bio-Techne TECH	£92.83 M	47.18%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£0.36 B	475.09%	🇺🇸 USA
Charles River Laboratories CRL	-£74.82 Million	-218.60%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions